Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder.

@article{Brignone2016EfficacyAT,
  title={Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder.},
  author={M{\'e}lanie Brignone and Françoise Diamand and Caroline Painchault and Shweta Takyar},
  journal={Current medical research and opinion},
  year={2016},
  volume={32 2},
  pages={351-66}
}
OBJECTIVES To assess the relative efficacy and tolerability of vortioxetine against different antidepressant monotherapies in patients with major depressive disorder (MDD) with inadequate response to selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) therapy. METHODS A systematic search was conducted for monotherapy studies in patients with MDD with inadequate response to first-line therapy. Treatments included SSRIs, SNRIs, and other… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
5 Citations
84 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 84 references

A randomised, double-blind, study of vortioxetine versus agomelatine in adults with major depressive disorder (MDD) with inadequate response to SSRI/SNRI treatment

  • L. Haggstrom
  • European Neuropsychopharmacology
  • 2013

Similar Papers

Loading similar papers…